Search

Meeting Coverage:

EURETINA Congress

EURETINA: 2018

Management of RVO

Anat Loewenstein, MD

Show Description +

Anat Loewenstein, MD, reviews the evaluation of patients with retinal vein occlusion. Dr. Loewenstein's discussion on which assessments are and are not necessary may have implications for efficient evaluation and management of disease. Dr. Loewenstein also discusses the connection between early intervention and treatment outcomes, and discusses the efficacy of treatment options such as anti-VEGF agents, steroids, and laser therapy.

Posted: 9/21/2018

Keywords:

Anti-VEGF

•

Euretina Vienna

•

Retinal Vein Occlusion, RVO

Up Next

Trials on Steroids for Diabetic Eye Disease

Trials on Steroids for Diabetic Eye Disease

Albert J. Augustin, MD

Is There Any Hope for Dry AMD Patients?

Is There Any Hope for Dry AMD Patients?

Anat Loewenstein, MD, William Tucker, MD

Understanding the ALTAIR Study

Understanding the ALTAIR Study

Masahito Ohji, MD

Three Exciting New Drugs

Three Exciting New Drugs

Pravin U. Dugel, MD

Value of Recent Surgical Innovations

Value of Recent Surgical Innovations

José García-Arumí, MD, PhD

The One Thing Every Doctor Can Do to Improve Efficiency in the Office

The One Thing Every Doctor Can Do to Improve Efficiency in the Office

Nadia K. Waheed, MD, MPH, Pravin U. Dugel, MD

Disrupted Imaging on OCTA

Disrupted Imaging on OCTA

Nadia K. Waheed, MD, MPH

Micropulse Laser in BRVO

Micropulse Laser in BRVO

Matteo Forlini, MD

Gene Therapy in Retinitis Pigmentosa

Gene Therapy in Retinitis Pigmentosa

Robert E. MacLaren, MB, ChB, DPhil, FRCOphth, FRCS, FACS, FMedSci

Can We Get Smaller Than 27-Gauge Instrumentation?

Can We Get Smaller Than 27-Gauge Instrumentation?

José García-Arumí, MD, PhD, Robert E. MacLaren, MB, ChB, DPhil, FRCOphth, FRCS, FACS, FMedSci

Can Technology Lead to a Seamless Diagnosis?

Can Technology Lead to a Seamless Diagnosis?

William Tucker, MD

Back to All Videos

Management of RVO

Anat Loewenstein, MD

Anat Loewenstein, MD, reviews the evaluation of patients with retinal vein occlusion. Dr. Loewenstein's discussion on which assessments are and are not necessary may have implications for efficient evaluation and management of disease. Dr. Loewenstein also discusses the connection between early intervention and treatment outcomes, and discusses the efficacy of treatment options such as anti-VEGF agents, steroids, and laser therapy.

Posted: 9/21/2018

Keywords:

Anti-VEGF

•

Euretina Vienna

•

Retinal Vein Occlusion, RVO

Please log in to leave a comment.

More From EURETINA: 2018 Coverage

Understanding the ALTAIR Study

Understanding the ALTAIR Study

Masahito Ohji, MD

Three Exciting New Drugs

Three Exciting New Drugs

Pravin U. Dugel, MD

Value of Recent Surgical Innovations

Value of Recent Surgical Innovations

José García-Arumí, MD, PhD

The One Thing Every Doctor Can Do to Improve Efficiency in the Office

The One Thing Every Doctor Can Do to Improve Efficiency in the Office

Nadia K. Waheed, MD, MPH, Pravin U. Dugel, MD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of EURETINA: 2018.